Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights several positive developments, including rate increases in Texas and Illinois, a 3.1% increase in hospice reimbursement rates, and a strategic focus on acquisitions and home-based care growth. The Q&A section further supports a positive outlook with strong hiring trends, successful caregiver app rollout, and positive integration of Gentiva. Despite potential risks like the proposed Medicare payment reduction, the company's optimistic guidance and strategic initiatives suggest a positive stock price movement over the next two weeks, especially given the small-cap market cap.
Total Revenue (Q4 2025) $373.1 million, an increase of 25.6% year-over-year from $297.1 million in Q4 2024. The growth was driven by acquisitions and organic growth in personal care services.
Adjusted Earnings Per Share (Q4 2025) $1.77, an increase of 28.3% year-over-year from $1.38 in Q4 2024. This was due to revenue growth and operational improvements.
Adjusted EBITDA (Q4 2025) $50.3 million, an increase of 33.3% year-over-year from $37.8 million in Q4 2024. The increase was attributed to revenue growth and cost management.
Total Revenue (2025) Approximately $1.4 billion, an increase of 23.2% year-over-year from approximately $1.1 billion in 2024. The growth was driven by acquisitions and organic growth.
Adjusted Earnings Per Share (2025) $6.23, an increase of 18.4% year-over-year from $5.26 in 2024. This was due to revenue growth and operational improvements.
Adjusted EBITDA (2025) $180 million, an increase of 28.3% year-over-year from $140.3 million in 2024. The increase was attributed to revenue growth and cost management.
Cash Flow from Operations (Q4 2025) $18.8 million. This was impacted by timing differences in payment cycles, particularly in Illinois.
Cash on Hand (Q4 2025) Approximately $81.6 million. This reflects consistent cash flow and debt reduction efforts.
Bank Debt (Q4 2025) $124.3 million, reduced by $30 million from the previous quarter. This reflects ongoing debt reduction efforts.
Personal Care Same-Store Revenue Growth (Q4 2025) 6.3% year-over-year. Growth was evenly divided between volume and rate increases.
Hospice Same-Store Revenue Growth (Q4 2025) 16% year-over-year. Growth was driven by operational improvements and increased admissions.
Home Health Same-Store Revenue Growth (Q4 2025) Decreased by 7.4% year-over-year. This was due to challenges in certain markets.
Gross Margin Percentage (Q4 2025) 32.8%, compared to 33.4% in Q4 2024. The decrease was due to a higher mix of personal care services from acquisitions.
G&A Expense (Q4 2025) 20.7% of revenue, down from 24% in Q4 2024. The decrease was due to lower acquisition expenses and higher revenue base.
Adjusted EBITDA Margin (Q4 2025) 13.6%, up from 12.9% in Q4 2024. The increase was due to revenue growth and cost management.
Revenue growth: Total revenue for Q4 2025 was $373.1 million, a 25.6% increase compared to Q4 2024. Full-year 2025 revenue was $1.4 billion, a 23.2% increase from 2024.
Adjusted earnings per share: Q4 2025 adjusted EPS was $1.77, a 28.3% increase from $1.38 in Q4 2024. Full-year 2025 adjusted EPS was $6.23, an 18.4% increase from $5.26 in 2024.
Adjusted EBITDA: Q4 2025 adjusted EBITDA was $50.3 million, a 33.3% increase from $37.8 million in Q4 2024. Full-year 2025 adjusted EBITDA was $180 million, a 28.3% increase from $140.3 million in 2024.
Geographic expansion: Acquisitions in 2025 included Great Lakes Home Care (Michigan), Helping Hands Home Care Service (Pennsylvania), and Del Cielo Home Care Services (Texas). These acquisitions expanded market coverage and geographic density.
Rate increases: Texas implemented a 9.9% rate increase effective September 1, 2025, and Illinois implemented a 3.9% rate increase effective January 1, 2026, expected to add $17.5 million in annualized revenue.
Hiring trends: Achieved 101 hires per business day in Q4 2025, increasing to 107 hires per business day in early January 2026. Hiring slowed temporarily due to severe weather but rebounded in February.
Segment performance: Personal Care segment same-store revenue grew 6.3% in Q4 2025. Hospice same-store revenue grew 16%, while Home Health same-store revenue decreased 7.4% compared to Q4 2024.
Acquisition strategy: Focused on acquisitions to increase geographic density and expand the full continuum of home-based care. Recent acquisitions contributed significantly to revenue growth.
Legislative efforts: Advocating for Medicaid rate increases and emphasizing the cost-effectiveness of home-based care to state governments.
Medicaid Rate Changes: Potential future changes to Medicaid due to OB3 could impact the company's financial performance. While the company believes in its value proposition, these changes could pose risks to revenue stability.
Hiring Challenges: Severe weather in certain markets caused a slowdown in hiring during January 2026, which could impact operational capacity. Additionally, clinical hiring remains challenging in some urban markets.
Home Health Revenue Decline: The Home Health segment experienced a 7.4% decrease in same-store revenue compared to the fourth quarter of 2024, raising concerns about the segment's performance and future growth.
Regulatory and Rate Uncertainty: Questions remain about potential future rate increases and the uncertainty of retrospective payment adjustments in the home health sector, which could affect financial planning and profitability.
Seasonal and Payroll Cost Impacts: Expected seasonal impacts and annual payroll tax resets are anticipated to negatively affect gross margin percentage in the first quarter of 2026.
DSO Increase in Illinois: Days Sales Outstanding (DSO) for the Illinois Department of Aging increased significantly in the fourth quarter of 2025, impacting cash flow and working capital.
Revenue Growth: The company expects the Illinois rate increase, effective January 1, 2026, to add approximately $17.5 million in annualized revenue with margins consistent in the low 20% range. Sequentially, from the fourth quarter of 2025 revenue of $371.2 million, the first quarter of 2026 is expected to benefit from the Illinois rate increase, offset by two fewer business days in personal care and some seasonal impact from winter storms.
Gross Margin: For the first quarter of 2026, gross margin percentage is expected to decline sequentially by approximately 120 basis points compared to the fourth quarter of 2025 due to annual merit increases and the normal annual reset of payroll taxes.
Tax Rate: The tax rate for calendar 2026 is expected to remain in the mid-20% range.
Acquisition Strategy: The company plans to selectively pursue acquisitions in 2026 that complement organic growth and align with its strategy, focusing on markets where it can leverage its strong personal care network and add clinical services to offer a full continuum of home-based care.
Cash Flow and Debt Management: The company will maintain a disciplined capital allocation strategy and continue to manage its net leverage ratio through ongoing debt reduction.
Market Trends: The company anticipates continued growth opportunities in home-based care due to heightened awareness of its value as a cost-effective and safe care option. It also expects the elimination of the 80/20 provision of the Medicaid access rule in the near future, which would be a significant development for the industry.
The selected topic was not discussed during the call.
The earnings call highlights several positive developments, including rate increases in Texas and Illinois, a 3.1% increase in hospice reimbursement rates, and a strategic focus on acquisitions and home-based care growth. The Q&A section further supports a positive outlook with strong hiring trends, successful caregiver app rollout, and positive integration of Gentiva. Despite potential risks like the proposed Medicare payment reduction, the company's optimistic guidance and strategic initiatives suggest a positive stock price movement over the next two weeks, especially given the small-cap market cap.
The earnings call summary and Q&A reveal strong financial performance, strategic expansions, and positive hiring trends, particularly in Texas. The company is executing well on acquisitions and capital allocation, with expectations for margin improvement in 2026. Despite some uncertainties, the overall sentiment is positive due to strategic growth initiatives and stable financial health. Given the market cap, the stock is likely to see a moderate positive reaction.
The earnings call highlights strong financial performance with a 20.3% revenue increase and a 25.1% rise in adjusted EBITDA. The company is actively expanding through acquisitions and has a solid cash position. The guidance remains optimistic with stable EBITDA margins and growth in personal care and home health segments. Despite some uncertainties in the Q&A, like the caregiver app's impact, overall sentiment is positive, supported by strategic acquisitions and potential favorable rate movements in key states. Given the company's small-cap status, these factors suggest a positive stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.